Stock comparison
Globus Medical
LeMaitre Vascular
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
GMED
Globus Medical
Market cap
$11.44B
Sector
Healthcare
LMAT
LeMaitre Vascular
Market cap
$2.23B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | GMED | LMAT | Winner |
|---|---|---|---|
| Warren Buffett | 58C | 77B | LMAT |
| Benjamin Graham | 65B | 89A | LMAT |
| Philip Fisher | 70C | 81C | LMAT |
| Peter Lynch | 63C | 67B | LMAT |
| Joel Greenblatt | 45D | 56D | LMAT |
| Charlie Munger | 51D | 68D | LMAT |
| Terry Smith | 56D | 69D | LMAT |
Side-by-side metrics
| Metric | GMED | LMAT |
|---|---|---|
| Market cap | $11.44B | $2.23B |
| P/E (TTM) | 17.7x | 37.1x |
| EV/EBIT | 20.6x | 36.6x |
| ROIC (TTM) | 9.72% | 9.43% |
| Gross margin | 67.86% | 72.39% |
| Net margin | 18.92% | 24.35% |
| Revenue CAGR 5y | 32.34% | 12.75% |
| EPS CAGR 5y | 28.06% | 19.04% |
| Debt / Equity | 0.0x | 0.5x |
| Dividend yield | 0.0% | 0.84% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
GMED leads on
- Debt / Equity0.0xvs 0.5x+95%
- Market cap$11.44Bvs $2.23B+80%
- Revenue CAGR 5y32.34%vs 12.75%+61%
- P/E (TTM)17.7xvs 37.1x+52%
LMAT leads on
- Dividend yield0.84%vs 0.0%+100%
- Net margin24.35%vs 18.92%+22%
- Gross margin72.39%vs 67.86%+6%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.